XML 32 R19.htm IDEA: XBRL DOCUMENT
v3.26.1

Aardwolf Spinoff | 6 Months Ended
--- | ---
Jun. 30, 2026
Aardwolf Spinoff [Abstract] |
Aardwolf Spinoff | 10. Aardwolf Spinoff In May 2022, through a series of transactions, the Company spun off certain assets of the Company (the "Spinoff") to Aardwolf Therapeutics, Inc. (“Aardwolf”). In accordance with authoritative guidance, the Company has determined that it holds a variable interest in Aardwolf and Aardwolf meets the definition of a variable interest entity (“VIE”) as Aardwolf does not have the ability to finance its activities without additional subordinated financial support and its equity investors will not absorb their proportionate share of expected losses. However, as the Company does not have both (i) the power to direct the economically significant activities of Aardwolf and (ii) the obligation to absorb losses of, or the right to receive benefits from, Aardwolf, the Company is not considered the primary beneficiary of Aardwolf and has not consolidated the financial position or results of operations of Aardwolf in the accompanying unaudited condensed consolidated financial statements, although Aardwolf is considered a related party of the Company. The Company will continuously perform this assessment, as changes to existing relationships or future transactions may result in the consolidation or deconsolidation of a VIE. At June 30, 2026 and December 31, 2025, the maximum exposure to loss was zero.

X
- Definition Aardwolf spinoff. + References No definition available. + Details
Name: | ck0001774857_AardwolfSpinoffAbstract
Namespace Prefix: | ck0001774857_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aardwolf spinoff. + References No definition available. + Details
Name: | ck0001774857_AardwolfSpinoffTextBlock
Namespace Prefix: | ck0001774857_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration